Spiritus Mundi (LSE:SPMU) Common Stock: £0.49 Mil (As of Mar. 2025)


What is Spiritus Mundi Common Stock?

Spiritus Mundi LSE:SPMU Common Stock is £0.49 Mil as of Mar. 2025.

Spiritus Mundi's quarterly common stock stayed the same from Mar. 2024 (£0.49 Mil) to Sep. 2024 (£0.49 Mil) and stayed the same from Sep. 2024 (£0.49 Mil) to Mar. 2025 (£0.49 Mil).

Spiritus Mundi's annual common stock increased from Mar. 2022 (£0.00 Mil) to Sep. 2023 (£0.49 Mil) but then stayed the same from Sep. 2023 (£0.49 Mil) to Sep. 2024 (£0.49 Mil).


Spiritus Mundi Common Stock Historical Data

* Premium members only.

The historical data trend for Spiritus Mundi's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spiritus Mundi Common Stock Chart

Spiritus Mundi Annual Data
Trend Mar22 Sep23 Sep24
Common Stock
0.00 0.49 0.49

Spiritus Mundi Semi-Annual Data
Mar22 Mar23 Sep23 Mar24 Sep24 Mar25
Common Stock Get a 7-Day Free Trial 0.49 0.49 0.49 0.49 0.49

Spiritus Mundi Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of £0.49 Mil mean?
Spiritus Mundi (LSE:SPMU) has a Common Stock of £0.49 Mil as of Mar. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Spiritus Mundi and its competitors.
Is Spiritus Mundi's Common Stock too high?
Spiritus Mundi's current Common Stock is £0.49 Mil.
How does Spiritus Mundi's Common Stock compare to PBAJ and SVMB?
Spiritus Mundi's Common Stock of £0.49 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Diversified Financial Services company?
A good Common Stock depends on the Diversified Financial Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Spiritus Mundi and its competitors. Spiritus Mundi's current Common Stock is £0.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spiritus Mundi stock overvalued right now?
Spiritus Mundi (LSE:SPMU) has a current Common Stock of £0.49 Mil. The current Common Stock is £0.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Spiritus Mundi (LSE:SPMU), the current Common Stock is £0.49 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spiritus Mundi Business Description

Address Westend\'s offices at 6 Heddon Street, London, GBR, W1B 4BT
Spiritus Mundi PLC is a special-purpose acquisition company incorporated in the United Kingdom. The company's only segment is to Identify and acquire investment projects in the clinical diagnostics sector which includes Clinical laboratory services (clinical lab); Clinical Diagnostics (PCR and blood test); and Digital Health (Healthcare IT platform).